|
Feasibility Study of a Chatbot AI-Driven Preliminary Screening System for Hereditary Cancer Syndromes
RECRUITINGSponsored by National Cancer Centre, Singapore
Actively Recruiting
SponsorNational Cancer Centre, Singapore
Started2026-07-21
Est. completion2027-07-21
Eligibility
Age21 Years – 99 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT07901543
Summary
This study aims to assess the feasibility of implementing an AI-based hereditary cancer preliminary screening system that has already been developed. This validation cohort will consist of healthy individuals and cancer patients, including those already suspected to be at risk of hereditary conditions.
Eligibility
Age: 21 Years – 99 YearsHealthy volunteers accepted
Inclusion Criteria: * Singapore citizen or permanent resident * Individuals from the general public or patients at NCCS * Adults (aged 21 or older) who are capable of giving informed consent Exclusion Criteria: * Under the age of 21 years old * Incapable of giving informed consent
Conditions2
CancerHereditary Cancer Syndromes
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
SponsorNational Cancer Centre, Singapore
Started2026-07-21
Est. completion2027-07-21
Eligibility
Age21 Years – 99 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT07901543